C12N 2710/14132
Use of virus as therapeutic agent, other than vaccine
Official title: Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
C12N2710/14132 (Use of virus as therapeutic agent, other than vaccine) appears on 4 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 4
- Assignees
- 8
- Inventors
- 17
- Latest grant
- 22 Sep 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2001 | 2 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Biopesticide22 Sep 2020US 10,779,543 B2Citrus Research International (Pty) Ltd
- Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein15 Jan 2002US 6,338,953 B1
- Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein20 Feb 2001US 6,190,887 B1Biogen, Inc.
- Complement-resistant non-mammalian DNA viruses and uses thereof6 Feb 2001US 6,183,993 B2Biogen, Inc.
- Plant disease control composition, plant disease control method, and use of organic silicone-based surfactant19 Mar 2026US 2026/0076375 A1Kaneka Corporation
- Pesticidal combinations of yersinia and insect viruses18 Nov 2021US 2021/0352913 A1Novozymes Bioag A/S
- Biopesticide30 May 2019US 2019/0159464 A1Citrus Research International (Pty) Ltd
- Anti-Cancer and Anti-Infectious Disease Compositions and Methods for Using Same3 Jul 2008US 2008/0159957 A1
Most cited
By later US patents
- Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein41US 6,338,953 B12002
- Complement-resistant non-mammalian DNA viruses and uses thereof18US 6,183,993 B2Biogen, Inc. · 2001
- Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein18US 6,190,887 B1Biogen, Inc. · 2001